Figure 1.
Sources of heterogeneity in double‐blind, placebo‐controlled (DBPC) randomized clinical trials (RCTs) of allergen immunotherapy (AIT) formulations
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.